Shares of Agenus Inc. (AGEN), which have nearly doubled in value year-to-date, trade around $6.
Agenus is an immuno-oncology company developing checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com